Natixis Advisors LLC Has $757,000 Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Natixis Advisors LLC trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 86.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 10,936 shares of the company's stock after selling 70,941 shares during the quarter. Natixis Advisors LLC's holdings in Henry Schein were worth $757,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. FMR LLC boosted its stake in shares of Henry Schein by 7.8% during the 3rd quarter. FMR LLC now owns 3,280,890 shares of the company's stock worth $239,177,000 after acquiring an additional 237,888 shares in the last quarter. Southpoint Capital Advisors LP lifted its holdings in shares of Henry Schein by 30.0% during the third quarter. Southpoint Capital Advisors LP now owns 2,600,000 shares of the company's stock valued at $189,540,000 after purchasing an additional 600,000 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of Henry Schein by 1.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,191,677 shares of the company's stock valued at $82,464,000 after purchasing an additional 16,616 shares during the period. ING Groep NV raised its holdings in Henry Schein by 34.1% during the 4th quarter. ING Groep NV now owns 1,163,087 shares of the company's stock worth $80,486,000 after buying an additional 295,785 shares during the period. Finally, Stifel Financial Corp lifted its stake in Henry Schein by 1.2% during the third quarter. Stifel Financial Corp now owns 1,122,455 shares of the company's stock valued at $81,827,000 after buying an additional 13,180 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Remove Ads

Insider Buying and Selling

In other news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. The trade was a 6.05 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Stock Down 1.1 %

NASDAQ:HSIC traded down $0.78 during trading hours on Friday, reaching $68.62. The company's stock had a trading volume of 1,028,798 shares, compared to its average volume of 1,573,330. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.49. The business's 50-day moving average is $74.62 and its 200-day moving average is $72.60. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market cap of $8.52 billion, a price-to-earnings ratio of 28.24, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the company posted $0.66 EPS. The business's revenue was up 5.8% on a year-over-year basis. Equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently issued reports on HSIC. Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 price target on the stock. Jefferies Financial Group increased their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. Bank of America raised Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.